Mcl Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Recruiting
  • CLL
  • +9 more
  • TG-1801
  • Ublituximab
  • Fayetteville, Arkansas
  • +4 more
2022-03-22
Mar 22, 2022
H
Recruiting
  • CLL/SLL
  • +8 more
  • Atlanta, Georgia
  • +3 more
2022-02-24
Feb 24, 2022
N
Recruiting
  • MCL
  • Mantle Cell Lymphoma
  • Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma
  • Odense, Denmark
  • +21 more
2022-02-11
Feb 11, 2022
I
Terminated
  • DLBCL
  • +2 more
  • Meldola, FC, Italy
    Nuclear Medicin Division, IRST IRCCS
2018-03-16
Mar 16, 2018